1-19 of 19
G. Hartung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Folinic Acid in Stage II and III Rectal Cancer: Interim Analysis

Subject Area:
Oncology
G. Hartung, W. Queißer, K. Maas, P. Diezler, E. Hagmüller, L. Edler, A. Kopp-Schneider, J. Weniger, A. Baur, T. Pabst, I. Jacob, C. Wojatschek, A. Seifert, H.-J. Weh, N. Janssen, M. Engel, H. Drost, H. Stockert, S. Lehnigk
Journal: Onkologie
Onkologie (1997) 20 (3): 231–234.
https://doi.org/10.1159/000218944
Published Online: 12 May 2009
View articletitled, Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Folinic Acid in Stage II and III Rectal Cancer: Interim Analysis
Open the PDF for Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Folinic Acid in Stage II and III Rectal Cancer: Interim Analysis in another window
Journal Articles

Adjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in Colorectal Cancer: Evaluation of Toxicity

Subject Area:
Oncology
G. Hartung, W. Queißer, P. Diezler, E. Hagmüller, L. Edler, I. Jacob, C. Wojatschek, A. Seifert, H. Weiss, H.-J. Weh, M. Hoffknecht, M.R. Clemens, D. Fritze, R. Katz, M. Härle
Journal: Onkologie
Onkologie (1996) 19 (1): 62–67.
https://doi.org/10.1159/000218760
Published Online: 12 May 2009
View articletitled, Adjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in Colorectal Cancer: Evaluation of Toxicity
Open the PDF for Adjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in Colorectal Cancer: Evaluation of Toxicity in another window
Journal Articles

Effective Secondary Neoadjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in a Patient with Cancer of the Colon

Subject Area:
Oncology
G. Hartung, D. Jentschura, M. Trede, W. Queißer
Journal: Onkologie
Onkologie (1995) 18 (2): 142–144.
https://doi.org/10.1159/000218575
Published Online: 11 May 2009
View articletitled, Effective Secondary Neoadjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in a Patient with Cancer of the Colon
Open the PDF for Effective Secondary Neoadjuvant Chemotherapy with 5-Fluorouracil and Folinic Acid in a Patient with Cancer of the Colon in another window
Journal Articles

Phase II Study of Subcutaneous Erythropoietin for Treatment of Myelodysplastic Syndromes (FAB Type I and II): A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society: A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society

Subject Area:
Oncology
G. Hartung, A. Weigold, S. Öhl, U. Essers, M.E. Heim, D. Fritze, M. Baldus, D. Hoelzer, K. Bremer, O. Quarder, L. Edler, W. Queißer
Journal: Onkologie
Onkologie (1995) 18 (5): 451–455.
https://doi.org/10.1159/000218634
Published Online: 11 May 2009
View articletitled, Phase II Study of Subcutaneous Erythropoietin for Treatment of Myelodysplastic Syndromes (FAB Type I and II): A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society: A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society
Open the PDF for Phase II Study of Subcutaneous Erythropoietin for Treatment of Myelodysplastic Syndromes (FAB Type I and II): A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society: A Trial of the Phase l/ll Study Group of the Association for Medical Oncology of the German Cancer Society in another window
Journal Articles

New Approaches to Adjuvant Therapy of Colorectal Carcinoma Including Current German Activities

Subject Area:
Oncology
G. Hartung, P. Diezler, E. Hagmüller, W. Queißer
Journal: Onkologie
Onkologie (1993) 16 (6): 416–424.
https://doi.org/10.1159/000218300
Published Online: 08 May 2009
View articletitled, New Approaches to Adjuvant Therapy of Colorectal Carcinoma Including Current German Activities
Open the PDF for New Approaches to Adjuvant Therapy of Colorectal Carcinoma Including Current German Activities in another window
Journal Articles

Prognostic Relevance of Peripheral Blood Counts and Bone Marrow Cytology in Chronic Myeloid Leukemia (CML)

Subject Area:
Oncology
W. Queißer, G. Hartung, H. Ansari, R. Hehlmann
Journal: Onkologie
Onkologie (1992) 15 (6): 480–489.
https://doi.org/10.1159/000217409
Published Online: 29 April 2009
View articletitled, Prognostic Relevance of Peripheral Blood Counts and Bone Marrow Cytology in Chronic Myeloid Leukemia (CML)
Open the PDF for Prognostic Relevance of Peripheral Blood Counts and Bone Marrow Cytology in Chronic Myeloid Leukemia (CML) in another window
Journal Articles

Spontaneous Remission of Chronic Lymphocytic Leukemia A Casuistic Contribution

Subject Area:
Oncology
M. Baldus, G. Hartung, W. Queißer
Journal: Onkologie
Onkologie (1992) 15 (6): 506–510.
https://doi.org/10.1159/000217413
Published Online: 29 April 2009
View articletitled, Spontaneous Remission of Chronic Lymphocytic Leukemia A Casuistic Contribution
Open the PDF for Spontaneous Remission of Chronic Lymphocytic Leukemia A Casuistic Contribution in another window
Journal Articles

Immunocytological Differentiation of Hepatocellular Carcinoma versus Extragonadal Germ Cell Tumor

Subject Area:
Oncology
J. Hastka, MH. Bohrer, G. Hartung, CS. Verbeke
Journal: Onkologie
Onkologie (1991) 14 (4): 344–345.
https://doi.org/10.1159/000217004
Published Online: 28 April 2009
View articletitled, Immunocytological Differentiation of Hepatocellular Carcinoma versus Extragonadal Germ Cell Tumor
Open the PDF for Immunocytological Differentiation of Hepatocellular Carcinoma versus Extragonadal Germ Cell Tumor in another window
Journal Articles

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

Subject Area:
Oncology
G. Hartung, R-D. Hofheinz, Y. Dencausse, J. Sturm, A. Kopp-Schneider, G. Dietrich, I. Fackler-Schwalbe, D. Bornbusch, M. Gonnermann, C. Wojatschek, W. Lindemann, H. Eschenburg, K. Jost, L. Edler, A. Hochhaus, W. Queisser
Journal: Onkologie
Onkologie (2005) 28 (6-7): 347–350.
https://doi.org/10.1159/000084595
Published Online: 02 June 2005
View articletitled, Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*
Open the PDF for Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study* in another window
Journal Articles

Neue Entwicklungen in der Chemotherapie gastrointestinaler Tumoren

Subject Area:
Oncology
G. Hartung
Journal: Onkologie
Onkologie (2001) 24 (Suppl. 5): 10–15.
https://doi.org/10.1159/000055181
Published Online: 17 November 2004
View articletitled, Neue Entwicklungen in der Chemotherapie gastrointestinaler Tumoren
Open the PDF for Neue Entwicklungen in der Chemotherapie gastrointestinaler Tumoren in another window
Journal Articles

Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer

Subject Area:
Oncology
R.-D. Hofheinz, S.-E. al-Batran, F. Hartmann, G. Hartung, D. Jäger, C. Renner, P. Tanswell, U. Kunz, A. Amelsberg, H. Kuthan, G. Stehle
Journal: Onkologie
Onkologie (2003) 26 (1): 44–48.
https://doi.org/10.1159/000069863
Published Online: 14 March 2003
View articletitled, Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer
Open the PDF for Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer in another window
Journal Articles

Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin

Subject Area:
Oncology
Y. Dencausse, G. Hartung, J. Sturm, A. Kopp-Schneider, E. Hagmüller, C. Wojatschek, H. Lindemann, D. Fritze, W. Queisser
Journal: Onkologie
Onkologie (2002) 25 (5): 426–430.
https://doi.org/10.1159/000067436
Published Online: 08 November 2002
View articletitled, Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin
Open the PDF for Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin in another window
Journal Articles

High-Dose 5-Fluorouracil / Folinic Acid in Combination with Three-Weekly Mitomycin C in the Treatment of Advanced Gastric Cancer. A Phase II Study

Subject Area:
Oncology
R.-D. Hofheinz, G. Hartung, S. Samel, A. Hochhaus, U. Pichlmeier, S. Post, R. Hehlmann, W. Queisser
Journal: Onkologie
Onkologie (2002) 25 (3): 255–260.
https://doi.org/10.1159/000064319
Published Online: 08 July 2002
View articletitled, High-Dose 5-Fluorouracil / Folinic Acid in Combination with Three-Weekly Mitomycin C in the Treatment of Advanced Gastric Cancer. A Phase II Study
Open the PDF for High-Dose 5-Fluorouracil / Folinic Acid in Combination with Three-Weekly Mitomycin C in the Treatment of Advanced Gastric Cancer. A Phase II Study in another window
Journal Articles

Adjuvant Radio-Chemotherapy in Stage II–III Rectal Cancer with 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid: Evaluation of Feasibility

Subject Area:
Oncology
Y. Dencausse, J. Sturm, G. Hartung, P. Dietzler, L. Edler, M. Bambach, C. Wojatschek, H. Lindemann, W. Qeißer
Journal: Onkologie
Onkologie (2001) 24 (5): 476–480.
https://doi.org/10.1159/000055129
Published Online: 26 October 2001
View articletitled, Adjuvant Radio-Chemotherapy in Stage II–III Rectal Cancer with 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid: Evaluation of Feasibility
Open the PDF for Adjuvant Radio-Chemotherapy in Stage II–III Rectal Cancer with 24-Hour Infusion of High-Dose 5-Fluorouracil and Folinic Acid: Evaluation of Feasibility in another window
Journal Articles

Phase II Study of a Weekly 24-Hour Infusion with 5-Fluorouracil and Simultaneous Sodium – Folinic Acid in the First-Line Treatment of Metastatic Colorectal Cancer

Subject Area:
Oncology
G. Hartung, R.-D. Hofheinz, A. Wein, C. Riedel, A. Rost, D. Fritze, E.-D. Kreuser, M. Drees, J. Kühnel, R. Hehlmann, W. Queisser
Journal: Onkologie
Onkologie (2001) 24 (5): 457–462.
https://doi.org/10.1159/000055126
Published Online: 26 October 2001
View articletitled, Phase II Study of a Weekly 24-Hour Infusion with 5-Fluorouracil and Simultaneous Sodium – Folinic Acid in the First-Line Treatment of Metastatic Colorectal Cancer
Open the PDF for Phase II Study of a Weekly 24-Hour Infusion with 5-Fluorouracil and Simultaneous Sodium – Folinic Acid in the First-Line Treatment of Metastatic Colorectal Cancer in another window
Journal Articles

Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial

Subject Area:
Oncology
G. Hartung, R. Hofheinz, D. Buchheidt, A. Rost, A. Brecht, K. Forche, M. Schröder, C. Wojatschek, D. Fritze, R. Hehlmann, W. Queisser
Journal: Onkologie
Onkologie (2000) 23 (5): 444–447.
https://doi.org/10.1159/000027215
Published Online: 03 November 2000
View articletitled, Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial
Open the PDF for Combination of Bolus 5-Fluorouracil, Folinic Acid and Mitomycin C in Advanced Gastric Cancer: Results of a Phase II Trial in another window
Journal Articles

Exacerbation of Wegener’s Granulomatosis following Single Administration of Monoclonal Antibody 17-1A (Panorex ® ) during Adjuvant Immunotherapy of Colon Cancer

Subject Area:
Oncology
A. Franz, H. Bewersdorf, G. Hartung, Y. Dencausse, W. Queisser
Journal: Onkologie
Onkologie (2000) 23 (5): 472–474.
https://doi.org/10.1159/000027216
Published Online: 03 November 2000
View articletitled, Exacerbation of Wegener’s Granulomatosis following Single Administration of Monoclonal Antibody 17-1A (Panorex ® ) during Adjuvant Immunotherapy of Colon Cancer
Open the PDF for Exacerbation of Wegener’s Granulomatosis following Single Administration of Monoclonal Antibody 17-1A (Panorex ® ) during Adjuvant Immunotherapy of Colon Cancer in another window
Journal Articles

Adaptation and Clinical Evaluation of a Homogenous Enzyme Multiplied Immunoassay Technique (EMIT) for Drug Monitoring of a Methotrexate-Albumin Conjugate (MTX-HSA) in Humans

Subject Area:
Oncology
G. Hartung, S. Heeger, T. Bertsch, E. Frei, A. Wunder, M. Kränzle, G. Stehle, M. Weigand, H.H. Schrenk, H. Sinn, W. Queisser
Journal: Onkologie
Onkologie (2000) 23 (4): 352–357.
https://doi.org/10.1159/000027169
Published Online: 07 September 2000
View articletitled, Adaptation and Clinical Evaluation of a Homogenous Enzyme Multiplied Immunoassay Technique (EMIT) for Drug Monitoring of a Methotrexate-Albumin Conjugate (MTX-HSA) in Humans
Open the PDF for Adaptation and Clinical Evaluation of a Homogenous Enzyme Multiplied Immunoassay Technique (EMIT) for Drug Monitoring of a Methotrexate-Albumin Conjugate (MTX-HSA) in Humans in another window
Journal Articles

Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Leucovorin in Stage II and III Rectal Cancer: 12 Months vs. 6 Months of Therapy. A Study of the Association for Medical Oncology of the German Cancer Society

Subject Area:
Oncology
G. Hartung, A. Kopp-Schneider, P. Diezler, E. Hagmüller, A. Baur, J. Weniger, C. Wojatshcek, N. Janssen, D. Hossfeld, H. Lindemann, T. Schnabel, L. Edler
Journal: Onkologie
Onkologie (2000) 23 (4): 334–339.
https://doi.org/10.1159/000027166
Published Online: 07 September 2000
View articletitled, Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Leucovorin in Stage II and III Rectal Cancer: 12 Months vs. 6 Months of Therapy. A Study of the Association for Medical Oncology of the German Cancer Society
Open the PDF for Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Leucovorin in Stage II and III Rectal Cancer: 12 Months vs. 6 Months of Therapy. A Study of the Association for Medical Oncology of the German Cancer Society in another window